Categories
FCPA Compliance Report

Joel Androphy on the Role of the FCA in Fighting Government Procurement Fraud


In the Episode, I am joined by Joel Androphy, co-founder at Berg & Androphy. Joel is well-known literally across the country as a white-collar defense lawyer and plaintiff’s counsel in high-profile False Claims Act litigation. With the ongoing Trump Administration’s bailouts and stimulus packages, there will be great temptations for fraud. There have already been several high-profile cases of companies returning bailout monies to which they were not entitled. In this podcast we consider the role of the FCA in helping the US government fight fraud, waste and abuse.
Some of the highlights include: 

  • Androphy believes the coronavirus bailout will cause great amount of fraud.
  • What is the role of the FCA in fighting government fraud, waste and abuse?
  • Why does Androphy believe that citizens who bring FCA cases are doing civic duty?
  • What are the different types of fraud perpetrated in government contracting?
  • Why is Androphy on a mission to have the federal bailout dollars benefit the American worker and not the American fraudster.

For more information on Joel Androphy, check out the firm website here.

Categories
Daily Compliance News

Daily Compliance News: May 15, 2019-the whistleblower protection edition

In today’s edition of Daily Compliance News:

Categories
Daily Compliance News

Daily Compliance News: April 5, 2019-the I feel very much loved edition

APRIL 5, 2019 BY TOM FOX


In today’s edition of Daily Compliance News:

Categories
FCPA Compliance Report

FCPA Compliance Report-Episode 421, Andrew Beato

In this episode I visit with Andrew Beato from the law firm of Stein Mitchell Beato & Missner LLP. We discuss the firm’s recent Federal Claims Act settlement with Walgreen on behalf of firm client  Marc Baker. Walgreens agreed to pay $60 million to settle allegations that it knowingly overcharged government healthcare plans such as Medicaid for prescription drugs. With this settlement, Walgreens resolved allegations that the company defrauded the U.S. government and 39 states by submitting false and inflated prices for prescription drugs to increase its government reimbursements. The settlement is one of the largest of its kind against a retail pharmacy under the qui tam whistleblower provisions of the False Claims Act. Some of the highlights of the podcast include:

  • The practice at Stein Mitchell Beato & Missner LLP;
  • What are qui tamwhistleblower protection under the FCA;
  • The allegations and resolution of the lawsuit against Walgreens.
  • Why are qui tam actions to powerful?
  • How do qui tam actions benefit the individual, the government and society as a whole?
  • How whistleblowers in such actions are in a private-public partnership to prevent government fraud, waste and abuse?

Resources
Stein Mitchell Beato & Missner LLP website
Andrew Beato LinkedIn profile
Case Name:     United States ex rel. Marc D. Baker v. Walgreen, Co., 12 Civ. 0300 (JPO) (S.D.N.Y.).